Immunic Appoints Jaa Roberson as Chief People Officer

Immunic appointed Jaa Roberson as Chief People Officer, effective the same day; she reports to CEO Erik Lundgren and joins the executive leadership team. She will lead global talent and organizational strategy to prepare the organization for the Phase 3 ENSURE read-out expected by the end of 2026 and for potential regulatory filings and commercialization of vidofludimus calcium (IMU-838).